Overall Status

Completed (8)

Recruiting (6)

Active, not recruiting (5)

Terminated (4)

Available (1)

Not yet recruiting (1)

Unknown status (1)

Withdrawn (1)

Phase

phase 2 (7)

phase 1 (6)

n/a (5)

phase 1/phase 2 (4)

phase 3 (1)

Collaborator

National Cancer Institute (NCI) (9)

Celgene Corporation (1)

Direct Therapeutics (1)

Merck Sharp & Dohme LLC (1)

University of California, Los Angeles (1)

Study Documents

Clinical Study Report (1)

Individual Participant Data Set (1)

Informed Consent Form (1)

Statistical Analysis Plan (1)

Study Protocol (1)

Study-level clinical trial data (1)

Intervention Type

drug (18)

procedure (6)

other (5)

behavioral (3)

biological (2)

device (1)

Funder Type

Other (14)

Industry (12)

NIH (1)

Study Type

Interventional (23)

Observational (3)

Expanded Access (1)

Glioma

Showing NaN - NaN of 27

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Glioblastoma Multiforme, Glioma Trial in Houston (Thalidomide, CPT-11, MRI Scan)

Completed

Has Results

Glioblastoma Multiforme
Glioma

Thalidomide
+3 more

Houston, Texas

U.T.M.D. Anderson Cancer Center

Feb 8, 2012

Glioma, Astrocytoma, Oligodendroglioma Trial in United States (Temozolomide and O6-Benzylguanine)

Terminated

Glioma
+3 more

Temozolomide and O6-Benzylguanine

Los Angeles, California
+11 more

Feb 7, 2012